Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pin

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 8, 2021
Editor's Choice - A Cost Effectiveness Analysis of Outpatient versus Inpatient Hospitalisation for Lower Extremity Arterial Disease Endovascular Revascularisation in France: A Randomised Controlled TrialYann Gouëffic, Jean L Pin, Jean Sabatier, et al.
Diabetes|December 27, 2021
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney DiseasesWilliam T Cefalu, Dana K Andersen, Guillermo Arreaza-Rubín, et al.
Nature Communications|March 18, 2022
Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemiaMoritz Binder, Ryan M Carr, Terra L Lasho, et al.
JCI Insight|December 31, 2024
EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in miceEmilie Jaune-Pons, Xiaoyi Wang, Fatemeh Mousavi, et al.
Epigenetics|July 31, 2018
Epigenetics of gastrointestinal diseases: notes from a workshopDavid L Marks, Rachel L Olson, Raul Urrutia, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Gastroenterology|July 29, 2019
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat DietYongde Luo, Yaying Yang, Muyun Liu, et al.
Cancer Research Communications|June 19, 2024
KRAS Promotes GLI2-Dependent Transcription during Pancreatic CarcinogenesisAshley N Sigafoos, Ezequiel J Tolosa, Ryan M Carr, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 8, 2021
Editor's Choice - A Cost Effectiveness Analysis of Outpatient versus Inpatient Hospitalisation for Lower Extremity Arterial Disease Endovascular Revascularisation in France: A Randomised Controlled TrialYann Gouëffic, Jean L Pin, Jean Sabatier, et al.
Diabetes|December 27, 2021
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney DiseasesWilliam T Cefalu, Dana K Andersen, Guillermo Arreaza-Rubín, et al.
Nature Communications|March 18, 2022
Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemiaMoritz Binder, Ryan M Carr, Terra L Lasho, et al.
JCI Insight|December 31, 2024
EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in miceEmilie Jaune-Pons, Xiaoyi Wang, Fatemeh Mousavi, et al.
Epigenetics|July 31, 2018
Epigenetics of gastrointestinal diseases: notes from a workshopDavid L Marks, Rachel L Olson, Raul Urrutia, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Gastroenterology|July 29, 2019
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat DietYongde Luo, Yaying Yang, Muyun Liu, et al.
Cancer Research Communications|June 19, 2024
KRAS Promotes GLI2-Dependent Transcription during Pancreatic CarcinogenesisAshley N Sigafoos, Ezequiel J Tolosa, Ryan M Carr, et al.
Pageof 6